{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:51:13Z","timestamp":1790405473808,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1124\/jpet.116.232538","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T04:49:24Z","timestamp":1457066964000},"page":"331-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Food and Drug Administration\u2013Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion"],"prefix":"10.1016","volume":"357","author":[{"given":"Claudio A.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy E.","family":"Vatner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Pachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Vatner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.232538_bib1","first-page":"H1327","article-title":"Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs","volume":"264","author":"Auchampach","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.116.232538_bib2","doi-asserted-by":"crossref","first-page":"e68009","DOI":"10.1371\/journal.pone.0068009","article-title":"Similarly potent inhibition of adenylyl cyclase by P-site inhibitors in hearts from wild type and AC5 knockout mice","volume":"8","author":"Braeunig","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.116.232538_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.113.208157","article-title":"Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds","volume":"347","author":"Brand","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.232538_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI112160","article-title":"Myocardial reperfusion: a double-edged sword?","volume":"76","author":"Braunwald","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.232538_bib5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1152\/ajplegacy.1960.199.6.1143","article-title":"Reactive hyperemia characteristics of the myocardium","volume":"199","author":"Coffman","year":"1960","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.116.232538_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00395-007-0687-7","article-title":"Adenosine: trigger and mediator of cardioprotection","volume":"103","author":"Cohen","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.116.232538_bib7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.106.669697","article-title":"Cardioprotection by ecto-5\u2032-nucleotidase (CD73) and A2B adenosine receptors","volume":"115","author":"Eckle","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.232538_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.yjmcc.2005.06.001","article-title":"Adenosine triggers preconditioning through MEK\/ERK1\/2 signalling pathway during hypoxia\/reoxygenation in neonatal rat cardiomyocytes","volume":"39","author":"Germack","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.116.232538_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.232538_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","article-title":"Cardiovascular adenosine receptors: expression, actions and interactions","volume":"140","author":"Headrick","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.116.232538_bib11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI108178","article-title":"Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs","volume":"56","author":"Heyndrickx","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.232538_bib12","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.2337\/db14-0494","article-title":"Adenylyl cyclase type 5 deficiency protects against diet-induced obesity and insulin resistance","volume":"64","author":"Ho","year":"2015","journal-title":"Diabetes"},{"key":"10.1124\/jpet.116.232538_bib13","doi-asserted-by":"crossref","first-page":"H2622","DOI":"10.1152\/ajpheart.00190.2012","article-title":"Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase","volume":"302","author":"Iwatsubo","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.116.232538_bib14","doi-asserted-by":"crossref","first-page":"40938","DOI":"10.1074\/jbc.M314238200","article-title":"Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration","volume":"279","author":"Iwatsubo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232538_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1601-183X.2006.00238.x","article-title":"Markedly attenuated acute and chronic pain responses in mice lacking adenylyl cyclase-5","volume":"6","author":"Kim","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1124\/jpet.116.232538_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2008.05592.x","article-title":"Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior","volume":"107","author":"Kim","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.116.232538_bib17","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.0508812103","article-title":"Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action","volume":"103","author":"Kim","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.232538_bib18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/cvr\/cvr215","article-title":"Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia","volume":"92","author":"Kudej","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.116.232538_bib19","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/CIRCULATIONAHA.112.001212","article-title":"Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1\/FoxO3a pathway","volume":"127","author":"Lai","year":"2013","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.232538_bib20","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1073\/pnas.95.12.6995","article-title":"A physiological role of the adenosine A3 receptor: sustained cardioprotection","volume":"95","author":"Liang","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.232538_bib21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0735-1097(99)00418-0","article-title":"Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial","volume":"34","author":"Mahaffey","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.116.232538_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1074248410396877","article-title":"Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?","volume":"17","author":"McIntosh","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/jpet.116.232538_bib23","doi-asserted-by":"crossref","first-page":"H2523","DOI":"10.1152\/ajpheart.00612.2007","article-title":"Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning","volume":"293","author":"Morrison","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.116.232538_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0008-6363(01)00358-3","article-title":"Adenosine, adenosine receptors and myocardial protection: an updated overview","volume":"52","author":"Mubagwa","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.116.232538_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0002-8703(92)90643-A","article-title":"The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury","volume":"123","author":"Norton","year":"1992","journal-title":"Am Heart J"},{"key":"10.1124\/jpet.116.232538_bib26","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCULATIONAHA.107.698662","article-title":"Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress","volume":"116","author":"Okumura","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.232538_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-8703(89)90723-0","article-title":"Controlled versus hyperemic flow during reperfusion of jeopardized ischemic myocardium","volume":"117","author":"Peng","year":"1989","journal-title":"Am Heart J"},{"key":"10.1124\/jpet.116.232538_bib28","doi-asserted-by":"crossref","first-page":"H1825","DOI":"10.1152\/ajpheart.495.2008","article-title":"Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation","volume":"295","author":"Rork","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.116.232538_bib29","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)","volume":"45","author":"Ross","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.116.232538_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/meth.1998.0593","article-title":"Inducible gene targeting in mice using the Cre\/lox system","volume":"14","author":"Sauer","year":"1998","journal-title":"Methods"},{"key":"10.1124\/jpet.116.232538_bib31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.108.788240","article-title":"Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning","volume":"118","author":"Shen","year":"2008","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.232538_bib32","first-page":"A15424","article-title":"Ghrelin attenuates myocardial ischemia\/reperfusion injury via the extracellular signal-regulated kinase 1\/2 and phosphatidylinositol 3-kinase\/Akt pathway","volume":"122","author":"Soeki","year":"2010","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.232538_bib33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/acel.12401","article-title":"Type 5 adenylyl cyclase disruption leads to enhanced exercise performance","volume":"14","author":"Vatner","year":"2015","journal-title":"Aging Cell"},{"key":"10.1124\/jpet.116.232538_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2131\/jts.41.115","article-title":"Antiviral drug vidarabine possessing cardiac type 5 adenylyl cyclase inhibitory property did not affect cardiohemodynamic or electrophysiological variables in the halothane-anesthetized dogs","volume":"41","author":"Wada","year":"2016","journal-title":"J Toxicol Sci"},{"key":"10.1124\/jpet.116.232538_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM199807163390307","article-title":"Hibernating myocardium","volume":"339","author":"Wijns","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.232538_bib36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1440-1681.2009.05300.x","article-title":"Adenosine A1 receptor activation reduces opening of mitochondrial permeability transition pores in hypoxic cardiomyocytes","volume":"37","author":"Xiang","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.116.232538_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2007.05.038","article-title":"Type 5 adenylyl cyclase disruption increases longevity and protects against stress","volume":"130","author":"Yan","year":"2007","journal-title":"Cell"},{"key":"10.1124\/jpet.116.232538_bib38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N Engl J Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.232538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:44:31Z","timestamp":1739994271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524193019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0022356524193019"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.232538","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Food and Drug Administration\u2013Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.232538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}